Tag: Microba
Drug Updates

Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis

Precision microbiome science company, Microba Life Sciences, will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D. Anatara have commenced recruitment for a phase 1/2 clinical trial of their Gastrointestinal Re-Programming complementary medicine (GaRP) to address an unmet clinical need for IBS-D.   Microba will apply […]
Drug Updates

International experts join Microba Life Sciences inaugural IBD Advisory Panel

Precision microbiome science company, Microba Life Sciences, has appointed three respected key opinion leaders in Inflammatory Bowel Disease (IBD) to their IBD Advisory Panel to translate research into clinical outcomes for IBD sufferers. Professors from Mount Sinai Doctors in the United States, Professor Jean-Frederic Colombel, MD and University of Miami Health System, Professor Maria Teresa Abreu […]